Immuno-Oncology Market

• Why should you buy this report?

• Learn all about the key trends in clinical trial development
• Gain a competitive assessment of Marketed PD-(L)1 checkpoint modulators
• Find out about the emergence of new immune checkpoint targets
• Discover clinical and commercial opportunities for highly anticipated CAR cell therapies

PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities

PharmaFocus: Visual Analysis of Immuno-Oncology Development and Opportunities

Our report provides unique, actionable insights applicable to I-O drugs in five major categories: Immune Checkpoint Modulators (Monoclonal Antibodies & Small Molecules), Cellular Immunotherapies (Cytotoxic Cellular Immunotherapies & Call-Based Vaccines), Oncolytic Viruses, Peptide Vaccines, and Bispecific T-Cell Engagers – you won’t find this information elsewhere. GlobalData analyzes over 4,000 clinical trials to generate a truly unique insight. A total of 18 solid tumor types and 8 hematological cancers are covered.

The field of I-O involves development of therapies that can harness the body’s ability to generate and sustain an effective immune response against cancer. GlobalData selected I-O products based on their molecular targets and molecular types. KOLs share their enthusiasm about I-O therapies that have impacted various oncology indications.